Each of our systems have unique energy ranges, applicators, and treatment capabilities. Learn which of our radiotherapy systems is right for you and your patients by watching the video below. Our Chief Science Officer, Amanda Tulk, outlines the key differences of each...
Clinicians use Xstrahl equipment to treat a variety of conditions Including non-melanoma skin cancer, and other benign and palliative applications.
Skin cancer is the most common cancer and the incidence is growing. Most are found in the head and neck. While surgery is the mainstay of treatment, it always leads to tissue sacrifice. New developments in radiotherapy (RT) have resulted in having almost similar...
Xstrahl has received FDA clearance for the marketing of its latest skin cancer therapy device. RADiant System is a compact and ergonomic superficial X-Ray therapy system operating in the 10kV to 80kV range intended for superficial radiotherapy and surface electronic...
A novel RADiant system provides a pain free, non-surgical alternative for the treatment of non-melanoma skin cancer and superficial keloid lesions. The Xstrahl (Camberley, United Kingdom) RADiant System is a mobile, compact, ergonomic superficial X-ray therapy...
October 17th, 2017 – The new Xstrahl RADiant System has been granted FDA 510(k) clearance for sale in the US. The RADiant System is a compact and ergonomic superficial X-Ray therapy system operating in the 10kV to 80kV range intended for superficial radiotherapy and...
Skin cancer of the head and neck comprise a heterogeneous mix of tumors with differing treatment response and outcomes depending upon histology. We present a large retrospective analysis of these tumors treated in a single institution over a 21-year period. We present...
Contact Us